Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations

Fang Liu, Sejal Ranmal, Hannah K. Batchelor, Mine Orlu-Gul, Terry B. Ernest, Iwan W. Thomas, Talia Flanagan, Catherine Tuleu

Research output: Contribution to journalReview articlepeer-review

190 Citations (Scopus)
22 Downloads (Pure)

Abstract

Patient acceptability of a medicinal product is a key aspect in the development and prescribing of medicines. Children and older adults differ in many aspects from the other age subsets of population and require particular considerations in medication acceptability. This review highlights the similarities and differences in these two age groups in relation to factors affecting acceptability of medicines. New and conventional formulations of medicines are considered regarding their appropriateness for use in children and older people. Aspects of a formulation that impact acceptability in these patient groups are discussed, including, for example, taste/smell/viscosity of a liquid and size/shape of a tablet. A better understanding of the acceptability of existing formulations highlights opportunities for the development of new and more acceptable medicines and facilitates safe and effective prescribing for the young and older populations.

Original languageEnglish
Pages (from-to)1871-1889
Number of pages19
JournalDrugs
Volume74
Issue number16
DOIs
Publication statusPublished - 2 Oct 2014

Keywords

  • pharmaceutical design
  • paediatric
  • geriatric
  • patient-centered pharmaceutical design

Fingerprint

Dive into the research topics of 'Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations'. Together they form a unique fingerprint.

Cite this